Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Conversion from Cyclosporine to Tacrolimus improves Renal Function and Lipid Profile after Cardiac Transplantation

Miroslaw Garlicki, Pawel Czub, Krzysztof Labus, Marek P Ehrlich, Hanna Rdzanek

Ann Transplant 2006; 11(1): 24-27 :: ID: 496936

Abstract

Background: Calcineurin inhibitors (CNIs) have become the cornerstone of immunosuppressive regimens following heart transplantation, but their use is associated with nephrotoxicity. The impact on renal function after conversion from cyclosporine (CsA) to tacrolimus (TAC) is reported. Patients and methods: Fifteen patients (men age 42±11 years) after cardiac transplantation (HTX) were switched from CsA to TAC (mean time after HTX 21±6 month). There were 13 male and 2 female patients. Mean cholesterol and LDL level at the time of conversion were 217±65 ml/dl and and 136±51 mg/100ml respectively. Indication for HTX was ischemic cardiomyopathy (CMP) in 8, congenital in 3 and dilatative CMP in the remaining 4 patients. Results: Mean tacrolimus level (μg/dl) at 1, 3, 6 and 12 months were 8.6±3.3, 8.6±1.4, 9.2±2.8 and 9.8±2.5 respectively. There was a statistically significant improvement in creatinine levels at 1, 3, 6 and 12 months after conversion from baseline 1.9±0.7mg/dl to 1.4±0,5 mg/dl, 1.4±0.4 mg/dl, 1.3±0.4 mg/dl and 1.2±0.4 mg/dl, respectively (p< 0.05). Furthermore, TAC decreased cholesterol as well as LDL-levels during this one-year time frame. Conclusion: This study shows that conversion from CsA to tacrolimus after orthotopic heart transplantation improves renal function.

Keywords: Heart Transplantation, Renal Function, lipid profile

Add Comment 0 Comments

In Press

02 Apr 2024 : Original article  

Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...

Ann Transplant In Press; DOI: 10.12659/AOT.943588  

02 Apr 2024 : Original article  

Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...

Ann Transplant In Press; DOI: 10.12659/AOT.943281  

03 Apr 2024 : Review article  

Alternative Therapies in Transplantology as a Promising Perspective in Medicine

Ann Transplant In Press; DOI: 10.12659/AOT.943387  

15 Apr 2024 : Original article  

Physical Activity Levels in Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.944101  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358